Articles tagged "Metabolic complications"

2020 American Transplant Congress
Early Corticosteroid Withdrawal in Pancreas and Simultaneous Pancreas-Kidney Transplant Recipients: Long-Term Clinical and Metabolic Outcomes of from a Single Center Retrospective Cohort
A. Lichvar, L. Lin, Y. Chen, Y. Yen, D. Pierce, A. Nadeem, P. West-Thielke, I. Tang, J. Almario, M. Spaggiari, I. Tzvetanov, E. Benedetti, M. Campara
University of Illinois at Chicago, Chicago, IL
*Purpose: Tacrolimus, mycophenolate mofetil, and chronic corticosteroids (CCS) are the most popular immunosuppression regimen after pancreas transplantation. Early corticosteroid withdrawal (ECSWD) is an increasingly popular…
2020 American Transplant Congress
Time-Trend of Metabolic Risks in Living Kidney Donors in South Korea
E. Kang¹, J. Park¹, S. Park¹, Y. Kim², J. Jeong³, J. An⁴, S. Lee⁵, S. Kim⁶, J. Cho⁷, M. Han⁸, H. Lee¹
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Korea, Republic of, ³Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of, ⁴Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea, Republic of, ⁵Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea, Republic of, ⁶Internal Medicine, Chonnam National University Hospital, Gwangju, Korea, Republic of, ⁷Internal Medicine, Kyungpook National University, Seoul, Korea, Republic of, ⁸Internal Medicine, Pusan National University Hospital, Pusan, Korea, Republic of
*Purpose: Considering westernized lifestyles and increasing prevalence of chronic diseases occurred in Korea, time-trend exploration of metabolic risk in live kidney donors may help to…
2020 American Transplant Congress
Incidence and Risk Factors of Post-Transplant Erythrocytosis in Deceased Donor Kidney Transplantation
S. Alasfar, Y. Jia, I. E. Hall, H. Thiessen Philbrook, S. G. Mansour, M. D. Doshi, S. Mohan, J. S. Bromberg, P. P. Reese, C. Parikh
DDS Consortium, Baltimore, MD
*Purpose: Post-transplant erythroytosis (PTE) is clinically important condition after kidney transplantation (KTx). Previously published literature from single-center studies, demonstrated variable incidence rates between 8-15%. We…
2020 American Transplant Congress
Characterization of Use and Safety of Non-Insulin Agents for Management of Post-Transplant Diabetes Mellitus in the Kidney Transplant Population
M. Norris¹, J. Trofe-Clark¹, C. Sammons¹, N. Casciello¹, S. Cardillo², D. Sawinski³, R. D. Bloom³, G. Malat¹
¹Pharmacy, Hosp of Univ of Pennsylvania, Philadelphia, PA, ²Endocrine Div, Univ of Pennsylvania, Philadelphia, PA, ³Renal Div, Univ of Pennsylvania, Philadelphia, PA
*Purpose: Newer, non-insulin agents appear to have significant cardiovascular benefits. However, use of these agents for diabetes (DM) management in kidney transplant recipients (KTR) has…
2020 American Transplant Congress
GLP1-RAs, SGLT2i Are Underutilized in Kidney Transplant Recipients with Diabetes Mellitus and Obesity
M. Stumpf, S. A. Dar, S. Rao, A. Doyle
University of Virginia, Charlottesville, VA
*Purpose: There is little research describing differences in use of antidiabetic medications amongst obese, diabetic patients with or without a history of kidney transplant. More…
2020 American Transplant Congress
Characterization of Gut Microbiome in Liver Transplant Recipients with Non-Alcoholic Steatohepatitis
S. Sataphaty¹, P. Banerjee², J. Pierre³, R. Heda³, S. Dutta³, D. D. Higgins⁴, V. Mas⁵, S. Khan⁶, V. Mupparaju³, S. R. Nair⁷, J. D. Eason⁸, D. Kleiner⁹, D. Maluf¹⁰
¹Department of Surgery, Division of Hepatology and Sandra Atlas Bass Center for Liver Diseases, Northwell Health, NYC, NY, ²School of Public Health, University of Memphis, Memphis, TN, ³University of Tennessee Health Science Center, Memphis, TN, ⁴University of Memphis, Memphis, TN, ⁵James D Eason Transplant Institute, Memphis, TN, ⁶Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, NYC, NY, ⁷Department of Surgery, James D Eason Transplant Institute, Memphis, TN, ⁸Department of Surgery, James D Eason Transplant Institute, NYC, TN, ⁹Laboratory of Pathology/National Cancer Institute, Bethesda, WA, ¹⁰Department of Surgery_ University of Tennessee, James D Eason Transplant Institute, NYC, TN
*Purpose: Non-alcoholic fatty liver disease (NAFLD) and its progressive form non-alcoholic steatohepatitis (NASH) is a growing problem globally and recurs even after liver transplant (LT).…
2020 American Transplant Congress
Long Term Outcome of Patients Transplanted for Non Alcoholic Steatohepatitis Related Cirrhosis
W. Alhamoudi¹, I. Salih², S. Yousif², M. Shawkat³, K. Bzeizi², S. Alghamdi², A. Albenmousa², D. Broering²
¹Medicine, King Saud University, Riyadh, Saudi Arabia, ²Liver Transplant, King Faisal Specialist Hospital, Riyadh, Saudi Arabia, ³Internal Medicine, Minia University, Minia, Egypt
*Purpose: Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver disease worldwide. Cirrhosis secondary to Nonalcoholic Steatohepatitis (NASH) is projected to…
2020 American Transplant Congress
Proportion of Veillonella and the Risk of New-Onset Diabetes Mellitus after Kidney Transplantation
K. Ji Eun¹, H. Kim¹, H. Cho², J. Park³, J. Lee⁴, D. Kim¹, K. Joo¹, Y. Kim¹, H. Lee¹
¹Seoul National University Hospital, Seoul, Korea, Republic of, ²Chungbuk National University Hospital, Cheongju, Korea, Republic of, ³Kangwon National University Hospital, Chuncheon, Korea, Republic of, ⁴Seoul National University Boramae Hospital, Seoul, Korea, Republic of
*Purpose: New-onset diabetes transplantation after transplantation (NODAT) is an important metabolic complication after kidney transplantation, although its mechanism is not yet fully elucidated. Recent studies…
2020 American Transplant Congress
Late Conversion from Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
J. Noble, F. Terrec, T. Jouve, H. Neciri Bennani, P. Benhamou, P. Malvezzi, B. Janbon, D. Giovannini, L. Rostaing
Nephrology and Transplant Unit, CHU Grenoble, Grenoble, France
*Purpose: Calcineurin inhibitors (CNIs) and steroids are strongly associated with new-onset diabetes after transplantation (NODAT), worsening of pre-existing diabetes, and cardiovascular events. We assessed the…
2020 American Transplant Congress
The Impact of Increased Visceral Fat in Kidney Transplant Recipients
Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika
Ehime University, Toon, Japan
*Purpose: An increased amount of visceral fat (VF) has been reported as a precursor to metabolic syndrome and is a risk factor for renal dysfunction.…